Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$287.89M
Total Bought:
$0
Total Sold:
$94.40M
Net Transaction:
-$94.40M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MapLight Therapeutics, Inc.(MPLT)950,011950,0110$19.31M$34.05M11.83%+$14.73M
Tyra Biosciences, Inc.(TYRA)1,029,2981,029,2980$39.42M$32.88M11.42%-$6.55M
Entrada Therapeutics, Inc.(TRDA)4,056,3794,056,3790$51.19M$29.85M10.37%-$21.34M
Pharvaris N V
COM
797,600797,6000$22.53M$27.58M9.58%+$5.05M
CAMP4 THERAPEUTICS CORPORATION(CAMP)5,869,0915,869,0910$25.88M$25.65M8.91%-$234.8K
Artiva Biotherapeutics, Inc.(ARTV)2,353,3042,353,3040$15.16M$22.83M7.93%+$7.67M
Tectonic Therapeutic, Inc.(TECX)606,660606,6600$18.75M$20.85M7.24%+$2.10M
Zentalis Pharmaceuticals, Inc.(ZNTL)3,947,9133,947,9130$9.24M$19.15M6.65%+$9.91M
Celldex Therapeutics, Inc.(CLDX)497,270497,2700$15.77M$18.50M6.43%+$2.73M
EyePoint, Inc.(EYPT)1,050,0001,050,0000$13.53M$15.02M5.22%+$1.48M
Biohaven Ltd.(BHVN)738,972738,9720$6.25M$11.00M3.82%+$4.74M
Surrozen, Inc.(SRZN)387,500271,250-116,250$11.29M$7.04M2.44%-$4.25M
Skye Bioscience, Inc.(SKYE)9,681,7639,681,7630$5.95M$6.71M2.33%+$762.0K
ALX Oncology Holdings Inc.(ALXO)3,057,3253,057,3250$6.13M$6.33M2.20%+$198.7K
Protara Therapeutics, Inc.(TARA)1,369,7821,369,7820$7.14M$5.23M1.82%-$1.90M
Silence Therapeutics plcADS(SLN)476,200476,2000$2.51M$5.23M1.82%+$2.72M
Centessa Pharmaceuticals PlcADS580,9450-580,945$23.08M$0—-$23.08M
Erasca, Inc.(ERAS)3,485,9710-3,485,971$56.40M$0—-$56.40M
GH Research PLC(GHRS)572,6650-572,665$8.05M$0—-$8.05M
Rallybio Corporation(RLYB)291,7880-291,788$2.62M$0—-$2.62M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q2 2026 | TickerTrail